Editor LSA

Penny Stocks Intraday Alert - HEMP, INC.(OTCMKTS:HEMP), Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT), Bio-Path Holdings Inc(OTCMKTS:BPTH), New Energy Technologies Inc(OTCMKTS:NENE)

 

Lewes, DE -- (SBWIRE) -- 10/10/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: HEMP, INC.(OTCMKTS:HEMP), Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT), Bio-Path Holdings Inc(OTCMKTS:BPTH), New Energy Technologies Inc(OTCMKTS:NENE).

HEMP, INC.(OTCMKTS:HEMP) ended lower -4.84% and complete the day at $0.0177. The total number of shares changed hands during the day was 12.30 million. After opening at $0.02, the stock hit as high as $0.02. However, it traded between $0.02 and $0.02 over the last twelve months.

Hemp, Inc. focuses on supplying services, products, and information related to the medical marijuana industry or to those who have an affinity for the medical marijuana industry.

Has HEMP Found The Bottom and Ready To Move Up? Find Out Here

Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT) closed yesterday at $0.900, a -5.16% decrease. Around 803,131 shares were traded, beating an-average trading volume of 729,228 shares. The company is now valued at around $115.76 million.

Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications.

Has PVCT Found The Bottom And Ready To Gain Momentum? Find Out Here

Bio-Path Holdings Inc(OTCMKTS:BPTH) moved +36.00 percent higher at $2.38 and traded between $1.70 and $2.48 after opening the day at $1.71. Its performance over the last five days remained 147.92%, which stands at 240% for a month. Going back further than one month, 1-year performance after recent close was 580%.

Bio-Path Holdings, Inc., a biotechnology company, focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Its lead product candidate, Liposomal Grb-2, is in a Phase I study for blood cancers and in preclinical studies for triple negative and inflammatory breast cancers.

For How Long BPTH Gloss will Attract Investors? Find out via this report

New Energy Technologies Inc(OTCMKTS:NENE) shares fall, losing -5.37 percent to close at $1.94. The stock is up around 100% this year and 68.7% for the last 12 months. Around 188,112 shares changed hands yesterday, higher from an-average trading volume of 84,639 shares.

New Energy Technologies, Inc. operates as a development stage renewable and alternative energy company. It develops SolarWindow electricity generating system, which facilitates to harvest light energy from the sun and artificial sources; and generate electricity from a see-through and semi-transparent coating of organic photovoltaic solar cells.

Will NENE Get Buyers Even After The Recent Rally? Find Out Here

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/